Login to Your Account

Other News To Note

Tuesday, July 3, 2012
• Cleveland BioLabs Inc., of Buffalo, N.Y., and its subsidiary Incuron LLC, of Moscow, said a study demonstrating that CBL0137 counteracted tumor formation in a mouse spontaneous breast cancer model was published online in Cancer Prevention Research.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription